Thermo Fisher Scientific (TMO) Competitors $532.35 -3.84 (-0.72%) As of 12:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WATShould you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector. Thermo Fisher Scientific vs. Its Competitors Medpace Agilent Technologies AMN Healthcare Services Danaher Haemonetics McKesson Qiagen West Pharmaceutical Services Mettler-Toledo International Waters Medpace (NASDAQ:MEDP) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations. Which has better earnings & valuation, MEDP or TMO? Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B7.01$404.39M$13.4539.13Thermo Fisher Scientific$43.21B4.65$6.34B$17.2930.79 Which has more risk and volatility, MEDP or TMO? Medpace has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Is MEDP or TMO more profitable? Medpace has a net margin of 18.74% compared to Thermo Fisher Scientific's net margin of 15.24%. Medpace's return on equity of 67.66% beat Thermo Fisher Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Medpace18.74% 67.66% 21.86% Thermo Fisher Scientific 15.24%16.82%8.38% Does the media favor MEDP or TMO? In the previous week, Thermo Fisher Scientific had 50 more articles in the media than Medpace. MarketBeat recorded 63 mentions for Thermo Fisher Scientific and 13 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.29 beat Medpace's score of 1.05 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 50 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate MEDP or TMO? Medpace presently has a consensus target price of $422.27, indicating a potential downside of 19.78%. Thermo Fisher Scientific has a consensus target price of $593.43, indicating a potential upside of 11.47%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 3 Sell rating(s) 12 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.00Thermo Fisher Scientific 0 Sell rating(s) 6 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.73 Do institutionals and insiders hold more shares of MEDP or TMO? 78.0% of Medpace shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 20.3% of Medpace shares are owned by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryThermo Fisher Scientific beats Medpace on 9 of the 16 factors compared between the two stocks. Get Thermo Fisher Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMO vs. The Competition Export to ExcelMetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$201.02B$6.94B$9.08B$21.91BDividend Yield0.32%1.16%5.69%3.58%P/E Ratio30.7927.6186.0129.70Price / Sales4.65195.34539.2263.33Price / Cash17.9521.7337.9224.43Price / Book4.115.4212.944.62Net Income$6.34B$178.04M$3.30B$1.01B7 Day Performance1.39%4.96%4.86%-0.08%1 Month Performance10.04%12.97%10.02%2.66%1 Year Performance-11.11%34.11%84.11%14.83% Thermo Fisher Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMOThermo Fisher Scientific4.8914 of 5 stars$532.35-0.7%$593.43+11.5%-9.9%$201.02B$43.21B30.79125,000Positive NewsAnalyst ForecastMEDPMedpace4.2313 of 5 stars$528.36-0.8%$422.27-20.1%+57.0%$14.90B$2.11B39.435,900Analyst ForecastAnalyst RevisionAAgilent Technologies4.0675 of 5 stars$141.75+0.1%$142.17+0.3%-2.6%$40.13B$6.51B33.2317,900Trending NewsAnalyst ForecastAMNAMN Healthcare Services4.2708 of 5 stars$19.98-2.7%$23.25+16.4%-50.4%$766.67M$2.77B-2.572,968News CoverageAnalyst ForecastDHRDanaher4.9812 of 5 stars$211.86-1.5%$245.91+16.1%-23.7%$151.85B$23.88B45.1263,000Trending NewsAnalyst ForecastHAEHaemonetics4.9321 of 5 stars$49.65-1.7%$78.78+58.7%-33.5%$2.40B$1.35B15.243,023Analyst ForecastAnalyst RevisionMCKMcKesson4.909 of 5 stars$741.93+0.5%$829.08+11.7%+52.6%$92.31B$359.05B29.5945,000Trending NewsAnalyst ForecastAnalyst RevisionQGENQiagen4.3702 of 5 stars$46.96+0.3%$49.40+5.2%+12.8%$10.42B$1.98B27.705,765Analyst ForecastWSTWest Pharmaceutical Services4.8743 of 5 stars$269.27-1.2%$321.89+19.5%-6.5%$19.38B$2.89B40.3510,600Analyst ForecastMTDMettler-Toledo International3.8999 of 5 stars$1,341.20+2.1%$1,328.33-1.0%-8.5%$27.60B$3.87B33.9317,300Analyst ForecastWATWaters4.5308 of 5 stars$328.230.0%$380.43+15.9%-8.6%$19.55B$3.05B29.617,600Trending NewsAnalyst Forecast Related Companies and Tools Related Companies Medpace Alternatives Agilent Technologies Alternatives AMN Healthcare Services Alternatives Danaher Alternatives Haemonetics Alternatives McKesson Alternatives Qiagen Alternatives West Pharmaceutical Services Alternatives Mettler-Toledo International Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMO) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredA Huge Shift Is Underway in AmericaWall Street legend issues chilling new warning: "I've never seen anything as dangerous as this" The man who...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
